Hosted on MSN
New weekly injectable drug could transform the lives of people living with Parkinson’s disease
A new weekly injection may soon transform how millions manage Parkinson’s disease. For over 8.5 million people living with this condition worldwide, daily treatment has meant taking levodopa and ...
Everyday Health on MSN
Do oral GLP-1 drugs work as well as injectables? We checked the science
FDA-approved oral GLP-1s match injectables in weight loss effectiveness with similar side effects and health benefits. There are differences, however.
The phase 2 trial of CT-388, a once-weekly subcutaneous injection acquired as part of its $2.7 billion takeover of Carmot ...
Operating under the FDA's 503B pathway, the Apex facility will prioritize the production of generic shortage-listed ...
As many as 12% of Americans are currently using GLP-1 medications such as Ozempic and Wegovy, according to one estimate.
Tiny self-propelled nanorobots use body chemistry to navigate directly to tumors and deliver cancer drugs more effectively.
LONDON (AP) — The European Medicines Agency has recommended authorizing a twice-yearly injectable drug aimed at preventing HIV, which scientists say could help end the virus’ transmission. In a ...
Health system pharmacists and clinicians are monitoring a wave of drug approvals expected throughout 2026, including first-in-class therapies and expanded uses of existing drugs with implications for ...
LONDON — The European Medicines Agency has recommended authorizing a twice-yearly injectable drug aimed at preventing HIV, which scientists say could help end the virus’ transmission. In a statement ...
FDA approves first generic florfenicol–flunixin injectable (nixiFLOR) for bovine respiratory disease
The FDA has approved nixiFLOR, the first generic florfenicol-flunixin injectable, for treatment of bovine respiratory disease and control of associated fever in beef and nonlactating dairy cattle.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results